#CancerUpdates
HER2-targeted therapy is showing real promise in rare bile duct cancers. Early results hint at a powerful new option for patients who’ve had far too few. Hope finally breaking through. #TCSC #CancerResearch #Oncology #MedicalNews #CancerUpdates #HealthBreakthrough

www.mdanderson.org/newsroom/res...
HER2-targeted therapy shows promising results in rare bile duct cancers
www.mdanderson.org
November 26, 2025 at 11:29 AM
Thrilled to speak this Thursday at the @TotalHealthConf Lung/GI #CancerUpdates
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
March 11, 2025 at 11:30 AM
1/2: Big news from the San Antonio Breast Cancer Symposium: Some early-stage breast cancer patients may safely skip lymph node removal without compromising outcomes. This could mean fewer side effects and better quality of life. #BreastCancer #CancerUpdates

apnews.com/article/brea...
Some breast cancer patients can avoid certain surgeries, studies suggest
Some early breast cancer patients can safely avoid certain surgeries. That's according to two studies published Thursday that explore ways to lessen treatment burdens.
apnews.com
December 13, 2024 at 7:49 PM
November 21, 2025 at 8:30 AM
🚨FDA Approval Alert!

✅ FDA grants full approval to Amgen's IMDELLTRA® (tarlatamab-dlle) in extensive stage small cell lung cancer (ES-SCLC).

🎯 Phase 3 DeLLphi-304 shows 40% reduction in risk of death vs chemo.

🔗 Read more: bit.ly/ONCOnews20N3

#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates
November 20, 2025 at 3:00 PM
November 20, 2025 at 1:00 PM